Find Clinical Trial

Study of a New Intravenous Drug, Called S65487, in Patients With Acute Myeloid Leukemia, Non Hodgkin Lymphoma or Multiple Myeloma

← Back
Study Phase Phase 1
Therapeutic Area Oncology
Active Substance S65487
SponsorInstitut de Recherches Internationales Servier
Active Substance CodeS65487
Protocol CodeCL1-65487-002
EudraCT Code
NCT CodeNCT03755154

Documents and links

Results are not yet available.

Servier Glossary of Terms

To ease the reading, we are developing a glossary of terms. In this glossary, we provide the lay terms used in our lay summaries and the corresponding medical terms. You will find the Servier Glossary of Terms on this link.

© 2017 LES LABORATOIRES SERVIER, an incorporated company of Servier.
All Rights Reserved. Servier does not sell its products over the Internet.
More information

Report a side-effect with a drug.